Jushi Holdings (JUSHF) Share-based Compensation (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly Share-based Compensation of $312000.0 for Q2 2026, down 16.58% year-over-year from $374000.0 in Q2 2025, and down 20.41% quarter-over-quarter from $392000.0 in Q1 2026.
Jushi Holdings (JUSHF) Share-based Compensation (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Share-based Compensation for 6 consecutive years, with $312000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Share-based Compensation fell 16.58% year-over-year to $312000.0; the TTM figure through Jun 2026 stood at $2.7 million (up 13.4% YoY), while the FY2025 annual figure was $2.1 million, down 50.14% from the prior year.
- Share-based Compensation retreated to $312000.0 in Q2 2026 per JUSHF's latest filing, from $392000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $7.0 million in Q1 2022 and bottomed at -$307000.0 in Q1 2025.
- Historically, Share-based Compensation has averaged $2.1 million across 5 years, with a median of $1.4 million in 2024.
- Annual changes were most pronounced in 2025 — Share-based Compensation tumbled 120.14% — and 2026, when it soared 227.69%.
- Jushi Holdings' Share-based Compensation stood at $6.0 million in 2022, then tumbled by 60.36% to $2.4 million in 2023, then slumped by 46.27% to $1.3 million in 2024, then soared by 32.47% to $1.7 million in 2025, then plunged by 81.44% to $312000.0 in 2026.
- Business Quant data shows JUSHF's Share-based Compensation at $312000.0 in Q2 2026, $392000.0 in Q1 2026, and $1.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | 312,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 312,000.00 |
| Jun 30, 2026 | 312,000.00 |
| Mar 31, 2026 | 392,000.00 |
| Mar 31, 2026 | 392,000.00 |
| Dec 31, 2025 | 1.68 Mn |
| Dec 31, 2025 | 1.68 Mn |
| Sep 30, 2025 | 357,000.00 |
| Sep 30, 2025 | 357,000.00 |
| Jun 30, 2025 | 374,000.00 |
| Jun 30, 2025 | 374,000.00 |
| Mar 31, 2025 | -307,000.00 |
| Mar 31, 2025 | -307,000.00 |
| Dec 31, 2024 | 1.27 Mn |
| Dec 31, 2024 | 1.27 Mn |
| Sep 30, 2024 | 1.08 Mn |
| Sep 30, 2024 | 1.08 Mn |
| Jun 30, 2024 | 347,000.00 |
| Jun 30, 2024 | 347,000.00 |
| Mar 31, 2024 | 1.52 Mn |
| Mar 31, 2024 | 1.52 Mn |